Is a complete ADXN research report available?

No complete published report is available for Addex Therapeutics Ltd (ADXN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Addex Therapeutics Ltd (ADXN)

NASDAQ: ADXN · USD

$2.89

-0.10 (-3.3%)· Recorded snapshot

Market cap	3.1M
Revenue (ttm)	102.8K
Net income (ttm)	-8.5M
EPS (ttm)	-$8.40
Shares out	127.4M
Volume	7,098
Beta	2.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 102.8K
Net income (ttm): -8.5M
EPS (ttm): -$8.40
Market cap: 3.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001574232
Company name	Addex Therapeutics Ltd
Country	Switzerland
Country code	US
CUSIP number	00654J206
Earnings date	2026-11-09
Earnings time	bmo
Employees	3
Employees change	1
Employees growth	50%
Enterprise value	$2.3M
Exchange	NASDAQ
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2002
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	US00654J2069
Last 10-K release date	2026-05-15
Last earnings date	2026-09-28
Last refreshed	2026-10-28
Last stock split date	2023-10-23
Last stock split type	Reverse
Market cap	$3.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$2.89
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ADXN
Website	https://www.addextherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001574232

Company name

Addex Therapeutics Ltd

Country

Switzerland

Country code

CUSIP number

00654J206

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

50%

Enterprise value

$2.3M

Exchange

NASDAQ

Financial currency

CHF

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2002

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

US00654J2069

Last 10-K release date

2026-05-15

Last earnings date

2026-09-28

Last refreshed

2026-10-28

Last stock split date

2023-10-23

Last stock split type

Reverse

Market cap

$3.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$2.89

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ADXN

Website

https://www.addextherapeutics.com

Metric	Value
Earnings yield	-290.8%
EV/Sales	23.01x
FCF / EV yield	-121.5%
FCF yield	-89.88%
P/B ratio	1.35x
P/S ratio	31.11x
Price / tangible book value	1.35x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-290.8%

EV/Sales

23.01x

FCF / EV yield

-121.5%

FCF yield

-89.88%

P/B ratio

1.35x

P/S ratio

31.11x

Price / tangible book value

1.35x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-3,130.68%
Pretax margin	-8,266.91%
Profit per employee	$-2.8M
Revenue per employee	$34,269
ROA	-27.12%
ROA (5Y)	-30.59%
ROCE	-122.88%
ROE	-150.58%
ROE (5Y)	-92.85%
ROIC	-35.19%
SBC / revenue	49.06%

Metric

Value

Operating margin

-3,130.68%

Pretax margin

-8,266.91%

Profit per employee

$-2.8M

Revenue per employee

$34,269

ROA

-27.12%

ROA (5Y)

-30.59%

ROCE

-122.88%

ROE

-150.58%

ROE (5Y)

-92.85%

ROIC

-35.19%

SBC / revenue

49.06%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth	-50.34%
Revenue growth (Q)	-72.65%
Revenue growth (QoQ)	29.35%
Revenue growth 10Y	-21.91%
Revenue growth 3Y	-66.19%
Revenue growth 5Y	-53.9%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-50.34%

Revenue growth (Q)

-72.65%

Revenue growth (QoQ)

29.35%

Revenue growth 10Y

-21.91%

Revenue growth 3Y

-66.19%

Revenue growth 5Y

-53.9%

Revenue growth years

Metric	Value
Depreciation and amortization	$-4,334
EBIT	$-3.2M
EBITDA	$-3.2M
EPS	$-8.40
FCF per share	$-0.02
Financing cash flow	$979,964
Free cash flow	$-2.9M
Free cash flow minus SBC	$-2.9M
Gross profit	$-336,853
Investing cash flow	$70,135
Net borrowing	$-45,650
Net cash flow	$-1.9M
Net income	$-8.5M
Operating cash flow minus SBC	$-2.9M
Operating income	$-3.2M
Revenue	$102,808
Stock-based compensation	$50,438

Metric

Value

Depreciation and amortization

$-4,334

EBIT

$-3.2M

EBITDA

$-3.2M

EPS

$-8.40

FCF per share

$-0.02

Financing cash flow

$979,964

Free cash flow

$-2.9M

Free cash flow minus SBC

$-2.9M

Gross profit

$-336,853

Investing cash flow

$70,135

Net borrowing

$-45,650

Net cash flow

$-1.9M

Net income

$-8.5M

Operating cash flow minus SBC

$-2.9M

Operating income

$-3.2M

Revenue

$102,808

Stock-based compensation

$50,438

Metric	Value
Altman Z-Score	-146.51
Book value per share	$0.02
Debt / equity	0.04
Interest coverage	-818.35
Long-term assets	$3.1M
Long-term liabilities	$302,803
Net cash (debt)	$853,754
Net cash / market cap	26.7%
Net cash growth	-69.51%
Net debt / equity	-0.36
Piotroski F-Score	1
Property, plant and equipment	$91,784
Shareholders' equity	$2.4M
Tangible book value	$2.4M
Tangible book value per share	$0.02
Total assets	$4.3M
Total cash	$949,663
Total debt	$95,910
Total liabilities	$1.9M
WACC	15.01%

Metric

Value

Altman Z-Score

-146.51

Book value per share

$0.02

Debt / equity

0.04

Interest coverage

-818.35

Long-term assets

$3.1M

Long-term liabilities

$302,803

Net cash (debt)

$853,754

Net cash / market cap

26.7%

Net cash growth

-69.51%

Net debt / equity

-0.36

Piotroski F-Score

Property, plant and equipment

$91,784

Shareholders' equity

$2.4M

Tangible book value

$2.4M

Tangible book value per share

$0.02

Total assets

$4.3M

Total cash

$949,663

Total debt

$95,910

Total liabilities

$1.9M

WACC

15.01%

Metric	Value
Asset turnover	0.01
Current assets	$1.3M
Current liabilities	$1.6M
Current ratio	0.76
Net working capital	$-1.3M
Quick ratio	0.58
Working capital	$-403,920
Working capital turnover	0.17

Metric

Value

Asset turnover

0.01

Current assets

$1.3M

Current liabilities

$1.6M

Current ratio

0.76

Net working capital

$-1.3M

Quick ratio

0.58

Working capital

$-403,920

Working capital turnover

0.17

Metric	Value
Buyback yield / dilution	-19.49%
Dividend yield	0%
Shareholder yield	-19.49%

Metric

Value

Buyback yield / dilution

-19.49%

Dividend yield

Shareholder yield

-19.49%

Metric	Value
150-day SMA	$5.47
1D price change	-3.34%
1M price change	-17.53%
1M total return	-17.53%
1W price change	-1.31%
1W total return	-1.31%
1Y price change	-69.66%
1Y return CAGR	-69.69%
1Y total return	-69.66%
20-day SMA	$3.00
200-day SMA	$6.09
3M price change	-48.85%
3M total return	-48.85%
3Y price change	-52.82%
3Y return CAGR	-22.15%
3Y total return	-52.82%
50-day SMA	$3.41
50-day SMA vs 200-day SMA	50under200
52-week high	$10.43
52-week high date	2026-01-13
52-week low	$2.56
52-week low date	2026-09-28
5Y price change	-98.01%
5Y return CAGR	-54.3%
5Y total return	-98.01%
6M price change	-54.32%
6M total return	-54.32%
All-time high	$750.40
All-time high date	2020-08-07
All-time low	$2.56
All-time low date	2026-09-28
Average true range (ATR)	$0.24
Average volume	6.8K
Beta (5Y)	2.02
Change from 52-week high	-72.29%
Change from 52-week low	12.89%
Change from all-time high	-99.6%
Change from all-time low	17.58%
Change from open	0%
Day's gap	-3.34%
Dollar volume	$20,513
High price	$2.89
Low price	$2.89
Monthly RSI	30.58
Open price	$2.89
Premarket change	0%
Premarket close	$2.99
Premarket price	$2.99
Previous close	$2.99
Price vs 150-day SMA	-44.97%
Price vs 20-day SMA	0.27%
Price vs 200-day SMA	-50.61%
Price vs 50-day SMA	-11.83%
Relative volume	1.05
RSI	46.14
Sharpe ratio	-0.55
Sharpe ratio (3Y)	0.03
Sharpe ratio (5Y)	-0.23
Sortino ratio	-0.72
Sortino ratio (3Y)	0.11
Sortino ratio (5Y)	-0.29
Volume	7.1K
Weekly RSI	29.02
YTD price change	-61.01%
YTD total return	-61.01%

Metric

Value

150-day SMA

$5.47

1D price change

-3.34%

1M price change

-17.53%

1M total return

-17.53%

1W price change

-1.31%

1W total return

-1.31%

1Y price change

-69.66%

1Y return CAGR

-69.69%

1Y total return

-69.66%

20-day SMA

$3.00

200-day SMA

$6.09

3M price change

-48.85%

3M total return

-48.85%

3Y price change

-52.82%

3Y return CAGR

-22.15%

3Y total return

-52.82%

50-day SMA

$3.41

50-day SMA vs 200-day SMA

50under200

52-week high

$10.43

52-week high date

2026-01-13

52-week low

$2.56

52-week low date

2026-09-28

5Y price change

-98.01%

5Y return CAGR

-54.3%

5Y total return

-98.01%

6M price change

-54.32%

6M total return

-54.32%

All-time high

$750.40

All-time high date

2020-08-07

All-time low

$2.56

All-time low date

2026-09-28

Average true range (ATR)

$0.24

Average volume

6.8K

Beta (5Y)

2.02

Change from 52-week high

-72.29%

Change from 52-week low

12.89%

Change from all-time high

-99.6%

Change from all-time low

17.58%

Change from open

Day's gap

-3.34%

Dollar volume

$20,513

High price

$2.89

Low price

$2.89

Monthly RSI

30.58

Open price

$2.89

Premarket change

Premarket close

$2.99

Premarket price

$2.99

Previous close

$2.99

Price vs 150-day SMA

-44.97%

Price vs 20-day SMA

0.27%

Price vs 200-day SMA

-50.61%

Price vs 50-day SMA

-11.83%

Relative volume

1.05

RSI

46.14

Sharpe ratio

-0.55

Sharpe ratio (3Y)

0.03

Sharpe ratio (5Y)

-0.23

Sortino ratio

-0.72

Sortino ratio (3Y)

0.11

Sortino ratio (5Y)

-0.29

Volume

7.1K

Weekly RSI

29.02

YTD price change

-61.01%

YTD total return

-61.01%

Metric	Value
Float	105.2M
Float percentage	82.53%
Shares change (QoQ)	3.43%
Shares change (YoY)	19.49%
Shares held by insiders	17.47%
Shares held by institutions	1.7%
Shares outstanding	127.4M
Short % of shares	0.12%
Short ratio	0.1 days

Metric

Value

Float

105.2M

Float percentage

82.53%

Shares change (QoQ)

3.43%

Shares change (YoY)

19.49%

Shares held by insiders

17.47%

Shares held by institutions

1.7%

Shares outstanding

127.4M

Short % of shares

0.12%

Short ratio

0.1 days

Addex Therapeutics Ltd (ADXN)

Price

Financial snapshot

Fair-value bridge

Latest news · ADXN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADXN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADXN

Frequently asked questions